Stem Cell Factor SOX9 Interacts with a Cell Death Regulator RIPK1 and Results in Escape of Cancer Stem Cell Death

• Published in: Cells (Basel, Switzerland) Switzerland), 2022-01, Vol.11 (3), p.363
• Main Authors: Oh, Mijung, Son, Chaeyeon, Rho, Seung Bae, Kim, Minjeong, Park, Kyoungsook, Song, Sang Yong
• Format: Article
• Language: English
• Subjects: Animals; Antibodies; Apoptosis; Biotechnology; cancer cell death; cancer stemness; Cancer therapies; Cell cycle; Cell Death; Cell Line, Tumor; Cell survival; Chemoresistance; Chemotherapy; Cytology; Cytoplasm; Gene Expression Regulation, Neoplastic; HGOC; Humans; Kinases; Lymph nodes; Malignancy; Medical prognosis; Metastases; Metastasis; Mice; Neoplasms - metabolism; Neoplastic Stem Cells - pathology; Ovarian cancer; Penicillin; Protein kinase; protein-protein interaction; Protein-serine/threonine kinase; Proteins; Receptor-Interacting Protein Serine-Threonine Kinases - genetics; Receptor-Interacting Protein Serine-Threonine Kinases - metabolism; RIPK1; Sodium; SOX9; Sox9 protein; SOX9 Transcription Factor - genetics; SOX9 Transcription Factor - metabolism; Stem cell factor; Stem cell transplantation; Stem cells; Tumors; Xenografts
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11030363

High-grade ovarian cancer (HGOC) is the most lethal gynecological cancer, with high metastasis and recurrence. Cancer stem cells (CSCs) are responsible for its apoptosis resistance, cancer metastasis, and recurrence. Thus, targeting CSCs would be a promising strategy for overcoming chemotherapy resistance and improving patient prognosis in HGOC. Among upregulated oncogenic proteins in HGOC, we found that transcription factor SOX9 showed a strong correlation with stemness-regulating ALDH1A1 and was localized predominantly in the cytoplasm of HGOC with lymph node metastasis. In order to address the role of unusual cytoplasmic SOX9 and to explore its underlying mechanism in HGOC malignancy, a Y2H assay was used to identify a necroptotic cell death-associated cytoplasmic protein, receptor-interacting serine/threonine protein kinase 1 (RIPK1), as a novel SOX9-interacting partner and further mapped their respective interacting domains. The C-terminal region containing the transactivation domain of SOX9 interacted with the death domain of R1PK1. Consistent with its stemness-promoting function, SOX9 knockdown in vitro resulted in changes in cell morphology, cell cycle, stem cell marker expression, cell invasion, and sphere formation. Furthermore, in vivo knockdown completely inhibited tumor growth in mouse xenograft model. We propose that cytoplasmic SOX9-mediated cell death suppression would contribute to cancer stem cell survival in HGOC.